These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 18794153

  • 1. Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development.
    Tran MA, Gowda R, Sharma A, Park EJ, Adair J, Kester M, Smith NB, Robertson GP.
    Cancer Res; 2008 Sep 15; 68(18):7638-49. PubMed ID: 18794153
    [Abstract] [Full Text] [Related]

  • 2. Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.
    Cheung M, Sharma A, Madhunapantula SV, Robertson GP.
    Cancer Res; 2008 May 01; 68(9):3429-39. PubMed ID: 18451171
    [Abstract] [Full Text] [Related]

  • 3. Targeting mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastases.
    Sharma A, Tran MA, Liang S, Sharma AK, Amin S, Smith CD, Dong C, Robertson GP.
    Cancer Res; 2006 Aug 15; 66(16):8200-9. PubMed ID: 16912199
    [Abstract] [Full Text] [Related]

  • 4. Melanoma prevention using topical PBISe.
    Chung CY, Madhunapantula SV, Desai D, Amin S, Robertson GP.
    Cancer Prev Res (Phila); 2011 Jun 15; 4(6):935-48. PubMed ID: 21367959
    [Abstract] [Full Text] [Related]

  • 5. Identification of aurora kinase B and Wee1-like protein kinase as downstream targets of (V600E)B-RAF in melanoma.
    Sharma A, Madhunapantula SV, Gowda R, Berg A, Neves RI, Robertson GP.
    Am J Pathol; 2013 Apr 15; 182(4):1151-62. PubMed ID: 23416158
    [Abstract] [Full Text] [Related]

  • 6. Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs.
    Yeh AH, Bohula EA, Macaulay VM.
    Oncogene; 2006 Oct 26; 25(50):6574-81. PubMed ID: 16715137
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Targeting mutant (V600E) B-Raf in melanoma interrupts immunoediting of leukocyte functions and melanoma extravasation.
    Liang S, Sharma A, Peng HH, Robertson G, Dong C.
    Cancer Res; 2007 Jun 15; 67(12):5814-20. PubMed ID: 17575149
    [Abstract] [Full Text] [Related]

  • 16. Identification of WEE1 as a target to make AKT inhibition more effective in melanoma.
    Kuzu OF, Gowda R, Sharma A, Noory MA, Kardos G, Madhunapantula SV, Drabick JJ, Robertson GP.
    Cancer Biol Ther; 2018 Jan 02; 19(1):53-62. PubMed ID: 28853983
    [Abstract] [Full Text] [Related]

  • 17. PRAS40 deregulates apoptosis in malignant melanoma.
    Madhunapantula SV, Sharma A, Robertson GP.
    Cancer Res; 2007 Apr 15; 67(8):3626-36. PubMed ID: 17440074
    [Abstract] [Full Text] [Related]

  • 18. KIT Suppresses BRAFV600E-Mutant Melanoma by Attenuating Oncogenic RAS/MAPK Signaling.
    Neiswender JV, Kortum RL, Bourque C, Kasheta M, Zon LI, Morrison DK, Ceol CJ.
    Cancer Res; 2017 Nov 01; 77(21):5820-5830. PubMed ID: 28947418
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
    Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F.
    Invest Ophthalmol Vis Sci; 2008 Jun 01; 49(6):2348-56. PubMed ID: 18281615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.